GlaxoSmithKline’s (GSK) former chief executive Andrew Witty was yesterday announced as the new CEO of Optum – a US payer organisation which includes pharmacy benefits manager OptumRx.

In May 2024, UHG CEO Andrew Witty testified before Congress about the cyberattack and the company's response, where he said that Optum will only seek repayment for the loans once the physician ...

Former GlaxoSmithKline chief executive Sir Andrew Witty has ... Organization (WHO). Witty is expected to return to his current role at US group UnitedHealth’s Optum health services business ...